CCO Expert Recap

Highlights of the 2008 International AIDS Conference

Source: CCO Official Conference Coverage of the 2008 International AIDS Conference

Highlights of the 2008 International AIDS Conference


Faculty:

Kathleen E. Squires, MD
  • Kathleen E. Squires, MD

CME CREDIT INFORMATION

Release Date: 09/25/08

Expiration Date: 09/24/09


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status


Begin the CCO Expert Recap

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe data on the relationship between baseline HIV-1 RNA and virologic response rates in patients receiving abacavir/lamivudine in several recent trials
  • Discuss the impact of baseline resistance to etravirine and/or darunavir on virologic response rates in patients in the DUET trials
  • Summarize recent findings on the impact of switching enfuvirtide to raltegravir in virologically suppressed patients
  • Restate the results of several recent analyses of the association between abacavir use and cardiovascular risk
  • Outline patterns of virologic response and adverse events by patient sex and patient race in several recent clinical studies

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Related Content

Related Tracks from this CCO Independent Conference Coverage:

Timing and Choice of First-Line Antiretroviral Therapy